EPISODE · May 17, 2026 · 3 MIN
今天3分钟我们来聊聊肝移植外新希望！干细胞疗法显神通
from 源于细胞BioInsid的个人播客
肝移植供体稀缺、费用高昂，多数肝硬化患者难以受益。王福生院士团队219例6年研究显示，脐带间充质干细胞输注可通过分化再生、分泌因子、免疫调节三重作用改善肝功能，患者生存率提升约30%，为肝病治疗带来新曙光。参考文献：Shi M, Li YY, Xu RN, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. DOI: 10.1007/s12072-021-10199-2王福生院士团队，219例HBV相关失代偿性肝硬化随机对照试验，75个月随访来源：肝功能研究学会公众号前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊肝移植外新希望！干细胞疗法显神通
0:00
3:44
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 3 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on May 17, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!